Craig A. Johnson's most recent trade in Heron Therapeutics Inc was a trade of 53,960 Common Stock done . Disclosure was reported to the exchange on Jan. 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 53,960 | 53,960 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Craig A. Johnson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 21 Nov 2025 | 6,039 | 14,592 (0%) | 0% | 15.7 | 94,692 | Common Shares |
| Aurinia Pharma Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 37,485 | 37,485 | - | - | Director Stock Option (right to buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 17,950 | 83,770 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 35,900 | 35,900 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 17,950 | 83,770 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 31,688 | 31,688 | - | - | Director Stock Option (right to buy) | |
| Aurinia Pharma Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 20,631 | 20,631 (0%) | 0% | 0 | Common Shares | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 83,685 | 83,685 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig Johnson A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 13,948 | 65,820 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 10,465 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 77,160 | 77,160 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 38,580 | 51,872 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 6,021 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 20,903 | 20,903 | - | - | Stock Option (Right to Buy) | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 10,452 | 13,292 (0%) | 0% | 0 | Common Stock | |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 9.73 per share. | 21 Dec 2021 | 250 | 2,840 (0%) | 0% | 9.7 | 2,432 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 12.30 per share. | 21 Sep 2021 | 250 | 3,090 (0%) | 0% | 12.3 | 3,074 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 15.20 per share. | 21 Jun 2021 | 250 | 3,340 (0%) | 0% | 15.2 | 3,801 | Common Stock |
| Heron Therapeutics Inc | Craig A. Johnson | Director | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 06 Apr 2021 | 250 | 3,590 (0%) | 0% | 17.2 | 4,305 | Common Stock |